Standard
Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum? / Jürgens, Gesche; Rasmussen, Henrik B; Werge, Thomas; Dalhoff, Kim; Nordentoft, Merete; Andersen, Stig E.
I:
Journal of Clinical Psychopharmacology, Bind 32, Nr. 1, 2012, s. 100-5.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Jürgens, G, Rasmussen, HB
, Werge, T, Dalhoff, K, Nordentoft, M & Andersen, SE 2012, '
Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?',
Journal of Clinical Psychopharmacology, bind 32, nr. 1, s. 100-5.
https://doi.org/10.1097/JCP.0b013e31823f6b6aAPA
Jürgens, G., Rasmussen, H. B.
, Werge, T., Dalhoff, K., Nordentoft, M., & Andersen, S. E. (2012).
Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum? Journal of Clinical Psychopharmacology,
32(1), 100-5.
https://doi.org/10.1097/JCP.0b013e31823f6b6aVancouver
Jürgens G, Rasmussen HB
, Werge T, Dalhoff K, Nordentoft M, Andersen SE.
Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum? Journal of Clinical Psychopharmacology. 2012;32(1):100-5.
https://doi.org/10.1097/JCP.0b013e31823f6b6aAuthor
Jürgens, Gesche ; Rasmussen, Henrik B ; Werge, Thomas ; Dalhoff, Kim ; Nordentoft, Merete ; Andersen, Stig E. / Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?. I: Journal of Clinical Psychopharmacology. 2012 ; Bind 32, Nr. 1. s. 100-5.
Bibtex
@article{7dfaf039c6fc4c1c93fce09e21387f41,
title = "Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?",
abstract = "Cytochrome P450 2D6 enzyme (CYP2D6) is an important metabolic pathway for many antipsychotics. Its genetic polymorphism causes pharmacokinetic variability that might lead to adverse drug reactions or treatment failure unless countered by appropriate dose adjustments or shift to CYP2D6-independent antipsychotics.",
author = "Gesche J{\"u}rgens and Rasmussen, {Henrik B} and Thomas Werge and Kim Dalhoff and Merete Nordentoft and Andersen, {Stig E}",
year = "2012",
doi = "10.1097/JCP.0b013e31823f6b6a",
language = "English",
volume = "32",
pages = "100--5",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}
RIS
TY - JOUR
T1 - Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?
AU - Jürgens, Gesche
AU - Rasmussen, Henrik B
AU - Werge, Thomas
AU - Dalhoff, Kim
AU - Nordentoft, Merete
AU - Andersen, Stig E
PY - 2012
Y1 - 2012
N2 - Cytochrome P450 2D6 enzyme (CYP2D6) is an important metabolic pathway for many antipsychotics. Its genetic polymorphism causes pharmacokinetic variability that might lead to adverse drug reactions or treatment failure unless countered by appropriate dose adjustments or shift to CYP2D6-independent antipsychotics.
AB - Cytochrome P450 2D6 enzyme (CYP2D6) is an important metabolic pathway for many antipsychotics. Its genetic polymorphism causes pharmacokinetic variability that might lead to adverse drug reactions or treatment failure unless countered by appropriate dose adjustments or shift to CYP2D6-independent antipsychotics.
U2 - 10.1097/JCP.0b013e31823f6b6a
DO - 10.1097/JCP.0b013e31823f6b6a
M3 - Journal article
C2 - 22198443
VL - 32
SP - 100
EP - 105
JO - Journal of Clinical Psychopharmacology
JF - Journal of Clinical Psychopharmacology
SN - 0271-0749
IS - 1
ER -
